Selected research
Industry Research
Hydroxyurea Tablets Industry Research Report 2026
Market perspective
The global Hydroxyurea Tablets market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Hydroxyurea Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Hydroxyurea Tablets is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Hydroxyurea Tablets is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Hydroxyurea Tablets include Bristol Myers Squibb, EVATIS, Medunik USA, TAJ Pharma, Anguo Yadong Biopharmaceutical, Beijing Jialin Pharmaceutical, Beijing Yanjing Pharmaceutical, Guangxi Nanning Baihui Pharmaceutical and Sinopharm Group Zhonglian Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Hydroxyurea Tablets market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Hydroxyurea Tablets Market by Company
Bristol Myers Squibb
EVATIS
Medunik USA
TAJ Pharma
Anguo Yadong Biopharmaceutical
Beijing Jialin Pharmaceutical
Beijing Yanjing Pharmaceutical
Guangxi Nanning Baihui Pharmaceutical
Sinopharm Group Zhonglian Pharmaceutical
Qilu Pharmaceutical
Shandong Anxin Pharmaceutical
Shanxi Zhendong Anxin Biopharmaceutical
Hydroxyurea Tablets Segment by Type
0.25g
0.5g
Hydroxyurea Tablets Segment by Application
Hospital
Clinic
Hydroxyurea Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hydroxyurea Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hydroxyurea Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hydroxyurea Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Hydroxyurea Tablets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Hydroxyurea Tablets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Hydroxyurea Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 0.25g
- 0.5g
Applications
- Hospital
- Clinic
Companies covered
- Bristol Myers Squibb
- EVATIS
- Medunik USA
- TAJ Pharma
- Anguo Yadong Biopharmaceutical
- Beijing Jialin Pharmaceutical
- Beijing Yanjing Pharmaceutical
- Guangxi Nanning Baihui Pharmaceutical
- Sinopharm Group Zhonglian Pharmaceutical
- Qilu Pharmaceutical
- Shandong Anxin Pharmaceutical
- Shanxi Zhendong Anxin Biopharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Hydroxyurea Tablets Market Size (2021-2032)
- 2.2.2 Global Hydroxyurea Tablets Sales (2021-2032)
- 2.2.3 Global Hydroxyurea Tablets Market Average Price (2021-2032)
- 2.3 Hydroxyurea Tablets by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 0.25g
- 2.3.3 0.5g
- 2.4 Hydroxyurea Tablets by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Hydroxyurea Tablets Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Hydroxyurea Tablets Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Hydroxyurea Tablets Revenue of Manufacturers (2021-2026)
- 3.4 Global Hydroxyurea Tablets Average Price by Manufacturers (2021-2026)
- 3.5 Global Hydroxyurea Tablets Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Hydroxyurea Tablets, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Hydroxyurea Tablets, Product Type & Application
- 3.8 Global Manufacturers of Hydroxyurea Tablets, Established Date
- 3.9 Global Hydroxyurea Tablets Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Bristol Myers Squibb
- 4.1.1 Bristol Myers Squibb Company Information
- 4.1.2 Bristol Myers Squibb Business Overview
- 4.1.3 Bristol Myers Squibb Hydroxyurea Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Bristol Myers Squibb Hydroxyurea Tablets Product Portfolio
- 4.1.5 Bristol Myers Squibb Recent Developments
- 4.2 EVATIS
- 4.2.1 EVATIS Company Information
- 4.2.2 EVATIS Business Overview
- 4.2.3 EVATIS Hydroxyurea Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 EVATIS Hydroxyurea Tablets Product Portfolio
- 4.2.5 EVATIS Recent Developments
- 4.3 Medunik USA
- 4.3.1 Medunik USA Company Information
- 4.3.2 Medunik USA Business Overview
- 4.3.3 Medunik USA Hydroxyurea Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Medunik USA Hydroxyurea Tablets Product Portfolio
- 4.3.5 Medunik USA Recent Developments
- 4.4 TAJ Pharma
- 4.4.1 TAJ Pharma Company Information
- 4.4.2 TAJ Pharma Business Overview
- 4.4.3 TAJ Pharma Hydroxyurea Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 TAJ Pharma Hydroxyurea Tablets Product Portfolio
- 4.4.5 TAJ Pharma Recent Developments
- 4.5 Anguo Yadong Biopharmaceutical
- 4.5.1 Anguo Yadong Biopharmaceutical Company Information
- 4.5.2 Anguo Yadong Biopharmaceutical Business Overview
- 4.5.3 Anguo Yadong Biopharmaceutical Hydroxyurea Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Anguo Yadong Biopharmaceutical Hydroxyurea Tablets Product Portfolio
- 4.5.5 Anguo Yadong Biopharmaceutical Recent Developments
- 4.6 Beijing Jialin Pharmaceutical
- 4.6.1 Beijing Jialin Pharmaceutical Company Information
- 4.6.2 Beijing Jialin Pharmaceutical Business Overview
- 4.6.3 Beijing Jialin Pharmaceutical Hydroxyurea Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Beijing Jialin Pharmaceutical Hydroxyurea Tablets Product Portfolio
- 4.6.5 Beijing Jialin Pharmaceutical Recent Developments
- 4.7 Beijing Yanjing Pharmaceutical
- 4.7.1 Beijing Yanjing Pharmaceutical Company Information
- 4.7.2 Beijing Yanjing Pharmaceutical Business Overview
- 4.7.3 Beijing Yanjing Pharmaceutical Hydroxyurea Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Beijing Yanjing Pharmaceutical Hydroxyurea Tablets Product Portfolio
- 4.7.5 Beijing Yanjing Pharmaceutical Recent Developments
- 4.8 Guangxi Nanning Baihui Pharmaceutical
- 4.8.1 Guangxi Nanning Baihui Pharmaceutical Company Information
- 4.8.2 Guangxi Nanning Baihui Pharmaceutical Business Overview
- 4.8.3 Guangxi Nanning Baihui Pharmaceutical Hydroxyurea Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Guangxi Nanning Baihui Pharmaceutical Hydroxyurea Tablets Product Portfolio
- 4.8.5 Guangxi Nanning Baihui Pharmaceutical Recent Developments
- 4.9 Sinopharm Group Zhonglian Pharmaceutical
- 4.9.1 Sinopharm Group Zhonglian Pharmaceutical Company Information
- 4.9.2 Sinopharm Group Zhonglian Pharmaceutical Business Overview
- 4.9.3 Sinopharm Group Zhonglian Pharmaceutical Hydroxyurea Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Sinopharm Group Zhonglian Pharmaceutical Hydroxyurea Tablets Product Portfolio
- 4.9.5 Sinopharm Group Zhonglian Pharmaceutical Recent Developments
- 4.10 Qilu Pharmaceutical
- 4.10.1 Qilu Pharmaceutical Company Information
- 4.10.2 Qilu Pharmaceutical Business Overview
- 4.10.3 Qilu Pharmaceutical Hydroxyurea Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Qilu Pharmaceutical Hydroxyurea Tablets Product Portfolio
- 4.10.5 Qilu Pharmaceutical Recent Developments
- 4.11 Shandong Anxin Pharmaceutical
- 4.11.1 Shandong Anxin Pharmaceutical Company Information
- 4.11.2 Shandong Anxin Pharmaceutical Business Overview
- 4.11.3 Shandong Anxin Pharmaceutical Hydroxyurea Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Shandong Anxin Pharmaceutical Hydroxyurea Tablets Product Portfolio
- 4.11.5 Shandong Anxin Pharmaceutical Recent Developments
- 4.12 Shanxi Zhendong Anxin Biopharmaceutical
- 4.12.1 Shanxi Zhendong Anxin Biopharmaceutical Company Information
- 4.12.2 Shanxi Zhendong Anxin Biopharmaceutical Business Overview
- 4.12.3 Shanxi Zhendong Anxin Biopharmaceutical Hydroxyurea Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Shanxi Zhendong Anxin Biopharmaceutical Hydroxyurea Tablets Product Portfolio
- 4.12.5 Shanxi Zhendong Anxin Biopharmaceutical Recent Developments
5 Global Hydroxyurea Tablets Market Scenario by Region
- 5.1 Global Hydroxyurea Tablets Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Hydroxyurea Tablets Sales by Region: 2021-2032
- 5.2.1 Global Hydroxyurea Tablets Sales by Region: 2021-2026
- 5.2.2 Global Hydroxyurea Tablets Sales by Region: 2027-2032
- 5.3 Global Hydroxyurea Tablets Revenue by Region: 2021-2032
- 5.3.1 Global Hydroxyurea Tablets Revenue by Region: 2021-2026
- 5.3.2 Global Hydroxyurea Tablets Revenue by Region: 2027-2032
- 5.4 North America Hydroxyurea Tablets Market Facts & Figures by Country
- 5.4.1 North America Hydroxyurea Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Hydroxyurea Tablets Sales by Country (2021-2032)
- 5.4.3 North America Hydroxyurea Tablets Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Hydroxyurea Tablets Market Facts & Figures by Country
- 5.5.1 Europe Hydroxyurea Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Hydroxyurea Tablets Sales by Country (2021-2032)
- 5.5.3 Europe Hydroxyurea Tablets Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Hydroxyurea Tablets Market Facts & Figures by Country
- 5.6.1 Asia Pacific Hydroxyurea Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Hydroxyurea Tablets Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Hydroxyurea Tablets Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Hydroxyurea Tablets Market Facts & Figures by Country
- 5.7.1 South America Hydroxyurea Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Hydroxyurea Tablets Sales by Country (2021-2032)
- 5.7.3 South America Hydroxyurea Tablets Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Hydroxyurea Tablets Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Hydroxyurea Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Hydroxyurea Tablets Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Hydroxyurea Tablets Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Hydroxyurea Tablets Sales by Type (2021-2032)
- 6.1.1 Global Hydroxyurea Tablets Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Hydroxyurea Tablets Sales Market Share by Type (2021-2032)
- 6.2 Global Hydroxyurea Tablets Revenue by Type (2021-2032)
- 6.2.1 Global Hydroxyurea Tablets Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Hydroxyurea Tablets Revenue Market Share by Type (2021-2032)
- 6.3 Global Hydroxyurea Tablets Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Hydroxyurea Tablets Sales by Application (2021-2032)
- 7.1.1 Global Hydroxyurea Tablets Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Hydroxyurea Tablets Sales Market Share by Application (2021-2032)
- 7.2 Global Hydroxyurea Tablets Revenue by Application (2021-2032)
- 7.2.1 Global Hydroxyurea Tablets Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Hydroxyurea Tablets Revenue Market Share by Application (2021-2032)
- 7.3 Global Hydroxyurea Tablets Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Hydroxyurea Tablets Value Chain Analysis
- 8.1.1 Hydroxyurea Tablets Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Hydroxyurea Tablets Production Mode & Process
- 8.2 Hydroxyurea Tablets Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Hydroxyurea Tablets Distributors
- 8.2.3 Hydroxyurea Tablets Customers
9 Global Hydroxyurea Tablets Analyzing Market Dynamics
- 9.1 Hydroxyurea Tablets Industry Trends
- 9.2 Hydroxyurea Tablets Industry Drivers
- 9.3 Hydroxyurea Tablets Industry Opportunities and Challenges
- 9.4 Hydroxyurea Tablets Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst